These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26722073)

  • 1. Neutrophil to Lymphocyte Ratio Predicts Therapeutic Outcome After Pancreaticoduodenectomy for Carcinoma of the Ampulla of Vater.
    Haruki K; Shiba H; Horiuchi T; Shirai Y; Iwase R; Fujiwara Y; Furukawa K; Misawa T; Yanaga K
    Anticancer Res; 2016 Jan; 36(1):403-8. PubMed ID: 26722073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater.
    Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Wakiyama S; Ishida Y; Yanaga K
    Anticancer Res; 2013 Jun; 33(6):2715-21. PubMed ID: 23749931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determinants of long-term survival after pancreaticoduodenectomy for ampulla of Vater carcinoma].
    Chen JY; Cai SW; Zhang WZ; Huang XQ; Liu R; Wang J; Chen YL; Ji WB; Shi XJ; Chen MY; Liu ZW; Zhao XQ; Feng YQ; Huang ZQ; Dong JH
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3409-12. PubMed ID: 20223115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of serum CA19-9 as a prognostic factor for the ampulla of Vater carcinoma.
    Kurihara C; Yoshimi F; Sasaki K; Iijima T; Kawasaki H; Nagai H
    Hepatogastroenterology; 2013 Oct; 60(127):1588-91. PubMed ID: 23933785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
    Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.
    Demirci NS; Erdem GU
    Bosn J Basic Med Sci; 2018 Aug; 18(3):268-274. PubMed ID: 29131967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of systemic inflammation in predicting the prognosis of ampulla of Vater carcinoma.
    Seo HK; Hwang DW; Lee JH; Song KB; Shin SH; Kwon J; Lee YJ; Kim SC
    Surg Oncol; 2019 Jun; 29():33-40. PubMed ID: 31196491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the ampulla of Vater: results of surgical treatment of a single center.
    Memon MA; Shiwani MH; Anwer S
    Hepatogastroenterology; 2004; 51(59):1275-7. PubMed ID: 15362731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduodenal local resection for low-risk group ampulla of vater carcinoma.
    Park JS; Yoon DS; Park YN; Lee WJ; Chi HS; Kim BR
    J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):737-42. PubMed ID: 18158802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of recurrence after pancreaticoduodenectomy for carcinoma of the ampulla of Vater].
    Chen J; Cai S; Dong J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1242-4. PubMed ID: 22985555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of surgical treatment of Vater's ampulla neoplasms.
    Bucher P; Chassot G; Durmishi Y; Ris F; Morel P
    Hepatogastroenterology; 2007 Jun; 54(76):1239-42. PubMed ID: 17629078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical technique for complete resection of the extrahepatic portion of the common bile duct and the ampulla of Vater for tumors of the ampulla of Vater.
    Aiura K; Shinoda M; Nishiyama R
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):276-81. PubMed ID: 20614155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of cancer of the ampulla of Vater: does local resection play a role?
    Lindell G; Borch K; Tingstedt B; Enell EL; Ihse I
    Dig Surg; 2003; 20(6):511-5. PubMed ID: 14506332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater.
    Yang K; Yun SP; Kim S; Shin N; Park DY; Seo HI
    BMC Gastroenterol; 2017 May; 17(1):70. PubMed ID: 28569146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy.
    Sun S; He C; Wang J; Huang X; Wu J; Li S
    BMC Cancer; 2020 Oct; 20(1):981. PubMed ID: 33036573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma.
    Demirci NS; Ozdemir NY; Erdem GU; Bozkaya Y; Yazici O; Zengin N
    Bratisl Lek Listy; 2018; 119(3):180-186. PubMed ID: 29536748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve years survival with repeated hepatectomy and lung resection for metastasis from carcinoma of the papilla of Vater after pancreaticoduodenectomy.
    Moriya T; Kimura W; Hirai I; Mizutani M; Yamamoto T; Toya R; Kamiga M; Fuse A
    Hepatogastroenterology; 2007 Sep; 54(78):1652-4. PubMed ID: 18019686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and operative factors for prognosis of carcinoma of the ampulla of vater.
    Inoue Y; Hayashi M; Hirokawa F; Egashira Y; Tanigawa N
    Hepatogastroenterology; 2012; 59(117):1573-6. PubMed ID: 22683975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.
    Shyr YM; Su CH; Wu LH; Li AF; Chiu JH; Wu CW; Lui WY
    Ann Surg; 1999 Apr; 229(4):523-7. PubMed ID: 10203085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.